CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
High ImpactOriginal article

Scholar Rock gets FDA nod for spinal muscular atrophy drug  

RegulatoryapprovedIsembyldPositive
AI Analysis

Summary

Scholar Rock received FDA approval for apitegromab (Isembyld), an injectable drug for spinal muscular atrophy, following previous manufacturing-related delays.

Outcome Details

FDA approval for injectable drug treating rare muscle-wasting disease

Importance:8/10
Sentiment:
0.85
FDA approvalrare diseasespinal muscular atrophyinjectablemanufacturing

Read the original article

Published by Endpoints News on September 14, 2026 11:29 AM

Read Original